Walleye Trading LLC Immuno Gen, Inc. Call Options Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $1.02 Million - $2.46 Million	82,100 Added 1909.3%	86,400 $2.56 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $23,953 - $33,779	1,700 Added 65.38%	4,300 $68,000
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $9,750 - $52,130	2,600 New	2,600 $49,000
Q2 2022 Aug 08, 2022	SELL	$3.15 - $5.76 $55,755 - $101,952	-17,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $44,730 - $78,540	10,500 Added 145.83%	17,700 $84,000
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $34,200 - $54,000	7,200 New	7,200 $53,000
Q1 2019 May 15, 2019	SELL	$2.41 - $5.91 $7,712 - $18,912	-3,200 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $11,032 - $27,159	2,800 Added 700.0%	3,200 $15,000
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $3,440 - $4,504	400 New	400 $4,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.